Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms

The objectives are as follows:
To assess the effects of discontinuation compared with continued use of anticholinergic drugs prescribed for antipsychotic-induced extrapyramidal symptoms in people with schizophrenia and related disorders including schizophreniform disorder, delusional disorder, psychosis and schizoaffective disorder.

Source: Current Awareness Service for Health (CASH) - May 22, 2017 Category: Consumer Health News Source Type: news